- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 16.63M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $50.51M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $51.5M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $3.09M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $2.75M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $136.4M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $134M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $31.5M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $29.29M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $87.15M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $86.26M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $101.47M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $97.16M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $220.45M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 16.52M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $372K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$81K |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | $0.08 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | $0.08 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $5.65M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $1.76M |
| Net Income | Q1 2025 · Mar 31, 2024 | $2.89M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $4.06M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $11.47M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $30.46M |
| Revenue | Q1 2025 · Mar 31, 2024 | $41.93M |